Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)

China flag China · Delayed Price · Currency is CNY
5.39
-0.12 (-2.18%)
Apr 29, 2026, 3:04 PM CST
Market Cap5.99B +38.0%
Revenue (ttm)2.37B -2.8%
Net Income-270.08M
EPS-0.25
Shares Out1.09B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume55,531,487
Average Volume36,492,702
Open5.60
Previous Close5.51
Day's Range5.32 - 5.60
52-Week Range4.20 - 6.74
Beta0.44
RSI58.50
Earnings DateApr 29, 2026

About SHE:002793

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and chan... [Read more]

Sector Healthcare
Founded 1998
Employees 3,196
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002793
Full Company Profile

Financial Performance

In 2025, SHE:002793's revenue was 2.27 billion, a decrease of -14.12% compared to the previous year's 2.65 billion. Losses were -288.58 million, -70.11% less than in 2024.

Financial Statements